tiprankstipranks
Trending News
More News >
Amylyx Pharmaceuticals Faces Challenges in Acquisition Strategy Amid RELYVRIO Discontinuation
PremiumCompany AnnouncementsAmylyx Pharmaceuticals Faces Challenges in Acquisition Strategy Amid RELYVRIO Discontinuation
2M ago
Amylyx Pharmaceuticals Reports 2024 Financial Results
Premium
Company Announcements
Amylyx Pharmaceuticals Reports 2024 Financial Results
2M ago
Amylyx Pharmaceuticals’ Earnings Call Highlights Clinical Progress
Premium
Company Announcements
Amylyx Pharmaceuticals’ Earnings Call Highlights Clinical Progress
2M ago
Amylyx appoints Dan Monahan as Chief Commercial Officer
PremiumThe FlyAmylyx appoints Dan Monahan as Chief Commercial Officer
4M ago
Gubra and Amylyx team on novel long-acting GLP-1 receptor antagonist development
Premium
The Fly
Gubra and Amylyx team on novel long-acting GLP-1 receptor antagonist development
4M ago
Amylyx Partners with Gubra for GLP-1 Antagonist
Premium
Company Announcements
Amylyx Partners with Gubra for GLP-1 Antagonist
4M ago
Amylyx reports Q3 EPS ($1.07), consensus (71c)
PremiumThe FlyAmylyx reports Q3 EPS ($1.07), consensus (71c)
6M ago
Amylyx upgraded to Buy at BofA on ‘underappreciated’ PBH opportunity
Premium
The Fly
Amylyx upgraded to Buy at BofA on ‘underappreciated’ PBH opportunity
6M ago
Amylyx upgraded to Buy from Neutral at BofA
Premium
The Fly
Amylyx upgraded to Buy from Neutral at BofA
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100